-
Mitoxantrone (INN, BAN, USAN; also
known as
Mitozantrone in Australia;
trade name Novantrone) is an
anthracenedione antineoplastic agent. Mitoxantrone...
-
Uramustine Aclarubicin Daunorubicin Doxorubicin Epirubicin Idarubicin Mitoxantrone Pirarubicin Valrubicin Zorubicin Abraxane Cabazitaxel Docetaxel Larotaxel...
-
overall survival (OS) is
markedly enhanced with
cabazitaxel versus mitoxantrone after prior docetaxel treatment.
FIRSTANA (ClinicalTrials.gov identifier:...
- - an
alkylating antineoplastic agent from the
oxazafosforine group;
Mitoxantrone - a
synthetic anthracycline analogue (anthraquinone) that can intercalate...
- is an
experimental antineoplastic (anti-cancer) drug, an
analogue of
mitoxantrone with
fewer toxic effects on
cardiac tissue. It acts as a topoisomerase...
-
often daunorubicin (can be
substituted for
doxorubicin or
idarubicin or
mitoxantrone).
There were
attempts to
intensify the "7+3"
regimen in
order to try...
- 2011,
mitoxantrone was the
first medication approved for
secondary progressive MS. In this po****tion,
tentative evidence supports mitoxantrone moderately...
-
sensitive to rituximab,
fludarabine and
mitoxantrone in
monotherapies (e.g.
multiple sclerosis).
Fludarabine Plus
Mitoxantrone With and
Without Rituximab Versus...
- ofatumumab, and ublituximab; and immunomodulators:
glatiramer acetate,
mitoxantrone, fingolimod, teriflunomide,
dimethyl fumarate, and
diroximel fumarate...
- and RPMS (rapidly progressive)
Primary progressive:
Ocrelizumab and
mitoxantrone are the only
approved drugs for PPMS. The last with restrictions. Secondary...
